The pediatric cardiology pharmacopeia: 2013 update
| Autor: | Sean Barnes, Shada Al-Anani, Aloka L. Patel, Yolandee Bell Cheddar, Hani Ghawi, Beth Shields, William Bonney, Umang Gupta, Steve D. Barnes, Joan Hoffman, Ismael Gonzalez, Rani Ganesan, Edmundo P. Cortez, Paul N. Severin, Sawsan Awad, Ra-id Abdulla, Kiran K. Mallula, S. M. Gendi, Suhaib Kazmouz |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Inotrope
Pharmacopoeias as Topic medicine.medical_specialty Heart Diseases business.industry MEDLINE Cardiology Disease Management Cardiovascular Agents Vascular surgery medicine.disease Pediatrics Cardiac surgery Heart failure Intervention (counseling) Pediatrics Perinatology and Child Health Cardiovascular agent medicine Humans Disease management (health) Cardiology and Cardiovascular Medicine Intensive care medicine business Child |
| Zdroj: | Pediatric cardiology. 34(1) |
| ISSN: | 1432-1971 |
| Popis: | The use of medications plays a pivotal role in the management of children with heart diseases. Most children with increased pulmonary blood flow require chronic use of anticongestive heart failure medications until more definitive interventional or surgical procedures are performed. The use of such medications, particularly inotropic agents and diuretics, is even more amplified during the postoperative period. Currently, children are undergoing surgical intervention at an ever younger age with excellent results aided by advanced anesthetic and postoperative care. The most significant of these advanced measures includes invasive and noninvasive monitoring as well as a wide array of pharmacologic agents. This review update provides a medication guide for medical practitioners involved in care of children with heart diseases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink